Guillain–Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: Case report and literature review
Author:
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Link
http://academic.oup.com/ecco-jcc/article-pdf/5/6/619/7800604/5-6-619.pdf
Reference23 articles.
1. Serious infections and mortality in association with therapies for Crohn's disease : TREAT registry;Lichtenstein;Clin Gastroenterol Hepatol,2006
2. Cancer in Crohn's disease patients treated with infliximab: a long-term multicenter matched-pair study;Biancone;Inflamm Bowel Dis,2011
3. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease;Cottone;Clin Gastroenterol Hepatol,2011
4. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations;Ananthakrishnan;Inflamm Bowel Dis,2009
5. Neurologic disorders associated with inflammatory bowel disease;Benavente;Eur J Neurol,2011
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Neurological Side Effects of TNF-α Inhibitors Revisited: A Review of Case Reports;Medicina;2024-08-28
2. Guillain-Barré Syndrome in a Patient Receiving Anti-Tumor Necrosis Factor for Crohn Disease: Coincidence or Consequence?;American Journal of Case Reports;2024-04-09
3. Immune-Mediated Neuropathies: Pathophysiology and Management;International Journal of Molecular Sciences;2023-04-14
4. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditions;Expert Opinion on Biological Therapy;2019-11-10
5. Síndrome de Guillain-Barré asociado al uso de Adalimumab en un paciente con colitis ulcerosa. A propósito de un caso;Acta Colombiana de Cuidado Intensivo;2019-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3